Hannah L. O’Mary
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 2
-
- Immunotherapy and Immune Responses 3
- Phagocytosis and Immune Regulation 1
- Pharmaceutical Science top 5%
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies 3
-
- RNA Interference and Gene Delivery 4
- Synthesis and bioactivity of alkaloids 1
- Extracellular vesicles in disease 1
-
- Adenosine and Purinergic Signaling 2
- Co-authors
- Zhengrong CuiSaijie ZhuMengmeng NiuLeena Kumari PrasadAbdulaziz M. AldayelSolange A. ValdesXu LiSachin G. Thakkar
- Partner nations
- United StatesSaudi ArabiaChina
In The Last Decade
Hannah L. O’Mary
10 papers receiving 561 citations
Peers
Comparison fields: 5 of 74
- Biomaterials 150
- Immunology 200
- Pharmaceutical Science 57
- Rheumatology 107
- Molecular Biology 251
Countries citing papers authored by Hannah L. O’Mary
This map shows the geographic impact of Hannah L. O’Mary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah L. O’Mary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah L. O’Mary more than expected).
Fields of papers citing papers by Hannah L. O’Mary
This network shows the impact of papers produced by Hannah L. O’Mary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah L. O’Mary. The network helps show where Hannah L. O’Mary may publish in the future.
Co-authorship network
The 23 scholars most cited alongside Hannah L. O’Mary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2022 | 2 | |
| 3 | 2019 | 15 | |
| 4 | 2018 | 106 | |
| 5 | 2017 | 15 | |
| 6 | 2016 | 43 | |
| 7 | 2016 | 18 | |
| 8 | 2015 | 110 | |
| 9 | 2013 | 190 | |
| 10 | 2012 | 55 |
About Hannah L. O’Mary
Hannah L. O’Mary is a scholar working on Physiology, Rheumatology, Immunology, Pharmaceutical Science and Biomaterials, having authored 10 papers that have together received 564 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Adenosine and Purinergic Signaling (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Synthesis and bioactivity of alkaloids (1 paper), Extracellular vesicles in disease (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Biomaterials (150 citations), Immunology (200 citations), Pharmaceutical Science (57 citations), Rheumatology (107 citations) and Molecular Biology (251 citations). Hannah L. O’Mary has collaborated with scholars based in United States, Saudi Arabia and China. Frequent co-authors include Zhengrong Cui, Saijie Zhu, Mengmeng Niu, Leena Kumari Prasad, Abdulaziz M. Aldayel, Solange A. Valdes, Xu Li, Sachin G. Thakkar, Dharmika S.P. Lansakara-P and Yue Li. Their work appears in journals such as Molecular Pharmaceutics, Biomaterials, Nanomedicine, Current Medicinal Chemistry and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.